An FDA advisory committee will meet next month to discuss an emergency use authorization (EUA) for Pfizer’s promising vaccine.
FDA advisory committee to discuss emergency authorization for Pfizer’s COVID-19 vaccine
More Stories
Record Korean Cases; Trader’s Guide to Rollout: Virus Update
California Hits Record; Trader’s Guide to Rollout: Virus Update
AstraZeneca to Buy Alexion for $39 Billion in Rare-Disease Push